CytoMed Therapeutics Limited - Ordinary Shares (NQ:GDTC)

0.9200 +0.0201 (+2.23%)

Delayed Quote Updated: 4:00 PM EDT, Oct 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about CytoMed Therapeutics Limited - Ordinary Shares

< Previous 1 2 3 Next >

Update on Clinical Milestone - CytoMed Therapeutics Announces First Patient Dosed in its First-in-Human Phase I Clinical Trial of Allogeneic CAR-Gamma Delta T Cell Therapy in Patients with Advanced Solid Tumours or Haematological Malignancies

November 20, 2024

From CYTOMED THERAPEUTICS LIMITED

Via GlobeNewswire

CytoMed Therapeutics completes cash acquisition of Cord Blood Banking Licence and Assets expanding CytoMed’s strategy to cord blood-derived biologics through subsidiary, LongevityBank

October 03, 2024

From CYTOMED THERAPEUTICS LIMITED

Via GlobeNewswire

CytoMed Therapeutics’ first-in-human Phase I ANGELICA clinical trial using its patented donor allogeneic chimeric antigen receptor T cell (CAR-T cell) against blood and solid tumors received co-funding support from the NMRC Clinical Trial Grant

October 07, 2024

Completion of cash acquisition of licenced cord blood bank expanding CytoMed’s strategy to cord blood-derived biologics through its subsidiary, LongevityBank Pte Ltd

From CYTOMED THERAPEUTICS LIMITED

Via GlobeNewswire

CytoMed Therapeutics Reports Six Months Ended June 30, 2024 Financial Results and Provides Clinical and Corporate Updates

September 30, 2024

From CYTOMED THERAPEUTICS LIMITED

Via GlobeNewswire

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday ↗

July 19, 2024

Pre-market stock movers are a hot topic on Friday as we check out all of the stories affecting shares on the last day of trading this week!

Via InvestorPlace

CytoMed Therapeutics Acquires Cord Blood Banking Licence and Assets to Entrench Its Strategy in Allogeneic, Off-the-shelf Donor-derived Gamma Delta (γδ) T Cells Technology for Solid and Liquid Cancers

July 17, 2024

Another Patent Granted for CytoMed's Allogeneic Induced Pluripotent Stem Cell (“iPSC”)-derived Hybrid Gamma Delta Natural Killer T (γδ NKT) cells technology

From CYTOMED THERAPEUTICS LIMITED

Via GlobeNewswire

Navigating the Challenges Facing an Aging Global Population: How CytoMed Seeks to Help Boost Cartilage Regeneration

March 20, 2024

The global population is rapidly aging. According to the World Population Prospects 2022 published by the United Nations, there were

Via Spotlight Growth

CytoMed Diversifies into Regenerative Medicine after Research Collaboration with Singapore's Sengkang General Hospital to Test Injectable Umbilical Cord-Derived Mesenchymal Stem Cells for Cartilage Regeneration

March 20, 2024

Via ACCESSWIRE

CytoMed Therapeutics to Launch Complimentary Cell Banking for Qualified Shareholders for Future Precision Therapies

March 18, 2024

From CYTOMED THERAPEUTICS LIMITED

Via GlobeNewswire

CytoMed Therapeutics Limited Announces Research Collaboration with Singapore Sengkang General Hospital to Advance Injectable Umbilical Cord-Derived Mesenchymal Stem Cells for Cartilage Diseases and Repair

March 04, 2024

CytoMed diversifies into regenerative medicine

From CYTOMED THERAPEUTICS LIMITED

Via GlobeNewswire

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

February 14, 2024

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

February 09, 2024

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

February 07, 2024

Via Benzinga

US Stocks Gain; Uber Posts Upbeat Sales ↗

February 07, 2024

U.S. stocks traded higher this morning, with the Dow Jones gaining around 100 points on Wednesday. Following the market opening Wednesday, the Dow traded up 0.25% to 38,618.79 while the NASDAQ rose...

Via Benzinga

Topics Stocks

Why Container Store Group Shares Are Trading Lower By Around 23%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

February 07, 2024

Shares of The Container Store Group, Inc. (NYSE: TCS) shares fell sharply during Wednesday’s session following weak quarterly results.

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

February 07, 2024

Via Benzinga

Malaysian Patent Granted for CytoMed Therapeutics' Licensed Allogeneic CAR-Gamma Delta T Cell Technology

January 29, 2024

The Company now has exclusive rights to a Malaysia, US and China patent

From CYTOMED THERAPEUTICS LIMITED

Via GlobeNewswire

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

January 15, 2024

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

December 27, 2023

Via Benzinga

Singapore’s Journey to Becoming a Biotech Powerhouse

October 24, 2023

Singapore's Biotech Vision: From 2000 Onwards In 2000, Singapore embarked on an ambitious mission to establish itself as a leading

Via Spotlight Growth

Topics Economy

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

October 09, 2023

Via Benzinga

CytoMed Expands Research Collaboration into China After Entering Into MOU

August 29, 2023

Via ACCESSWIRE

Singapore’s Leap into the Future of Cell and Gene Therapies

August 29, 2023

Singapore is making remarkable progress in the realm of cell and gene therapy (CGT), as evidenced by the inauguration of

Via Spotlight Growth

Week In Review: Hengrui Out-Licenses Novel Anti-Inflammatory To One Bio In $1 Billion Deal ↗

August 19, 2023

Jiangsu Hengrui Pharma out-licensed global rights (ex-China) for a novel anti-inflammatory to One Bio of Florida in a $1 billion deal. One Bio will make an $21.5 million payment upfront along with a...

Via Talk Markets

The Dawn of a New Era in Immunotherapy for Cancers: Understanding CytoMed Therapeutics’ (NASDAQ: GDTC) iPSC-Derived Gamma Delta NKT Cell Technology

July 27, 2023

CytoMed Therapeutics, a NASDAQ-listed company (Stock Symbol: GDTC), is at the forefront of a revolution in cellular therapy for cancers.

Via Spotlight Growth

Benzinga's Top Ratings Upgrades, Downgrades For July 21, 2023 ↗

July 21, 2023

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

July 13, 2023

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

July 12, 2023

Via Benzinga

Why Lucid Group Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

July 12, 2023

Gainers Healthcare Triangle, Inc. (NASDAQ: HCTI) shares climbed 171.2% to $8.84 as the company launched initiative to prevent ransomware attacks in the $35 billion healthcare data market.

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

July 12, 2023

Via Benzinga

< Previous 1 2 3 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.